Prudent Man Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Buy |
3,201
+91
| +3% | +$6.36K | 0.07% | 157 |
|
|
2025
Q1 | $229K | Hold |
3,110
| – | – | 0.08% | 148 |
|
|
2024
Q4 | $204K | Hold |
3,110
| – | – | 0.07% | 162 |
|
|
2024
Q3 | $242K | Buy |
3,110
+16
| +0.5% | +$1.25K | 0.08% | 151 |
|
|
2024
Q2 | $241K | Hold |
3,094
| – | – | 0.09% | 143 |
|
|
2024
Q1 | $210K | Sell |
3,094
-667
| -18% | -$45.2K | 0.08% | 162 |
|
|
2023
Q4 | $253K | Sell |
3,761
-171
| -4% | -$11.5K | 0.09% | 147 |
|
|
2023
Q3 | $266K | Sell |
3,932
-131
| -3% | -$8.87K | 0.11% | 144 |
|
|
2023
Q2 | $291K | Hold |
4,063
| – | – | 0.11% | 144 |
|
|
2023
Q1 | $282K | Hold |
4,063
| – | – | 0.11% | 146 |
|
|
2022
Q4 | $275K | Buy |
+4,063
| New | +$275K | 0.11% | 153 |
|
|
2022
Q2 | – | Sell |
-3,164
| Closed | -$210K | – | 166 |
|
|
2022
Q1 | $210K | Buy |
+3,164
| New | +$210K | 0.09% | 173 |
|
|
2021
Q4 | – | Sell |
-3,855
| Closed | -$232K | – | 188 |
|
|
2021
Q3 | $232K | Hold |
3,855
| – | – | 0.09% | 177 |
|
|
2021
Q2 | $231K | Buy |
+3,855
| New | +$231K | 0.09% | 187 |
|
|
2020
Q4 | – | Sell |
-3,731
| Closed | -$204K | – | 183 |
|
|
2020
Q3 | $204K | Sell |
3,731
-60
| -2% | -$3.28K | 0.11% | 152 |
|
|
2020
Q2 | $201K | Buy |
+3,791
| New | +$201K | 0.18% | 144 |
|